The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed pounds.

Weight loss drugs are all the rage right now. From the more popular options like Mounjaro or Ozempic – which is technically a diabetes medication that also helps with weight management – to emerging medications like WeGovy and Zepbound,

Noom on Thursday announced it is offering users access to compounded semaglutide as part of a new weight loss product starting at $149. The digital health company already offers branded GLP-1s through its platform,

The psychology-based digital healthcare platform Noom announced Thursday that is now offering off-brand weight loss drugs for one of the cheapest starting prices in the industry.